A structural spectroscopic study of dissociative anaesthetic methoxphenidine
Bronislav Jurásek, Patrik Fagan, Bohumil Dolenský, Natalie Paškanová, Kristýna Dobšíková, Ivan Raich, Radek Jurok, Vladimı́r Setnička, Michal Kohout, Jan Čejka, Martin Kuchař
New Journal of Chemistry 2023 DOI: 10.1039/d2nj06126k (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Keywords | Dissociative Local anaesthetic General anaesthetic Pharmacology Anesthesia General anaesthesia |
| Citations | 6 |
| Key points | Methoxphenidine was originally patented for its properties to treat neurotoxic injury. |
Abstract
Methoxphenidine was originally patented for its properties to treat neurotoxic injury.
Citations in the library
Cites 16
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms Pharmacological Reviews June 26, 2018
- Mechanisms of Ketamine Action as an Antidepressant Molecular Psychiatry March 13, 2018
- Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and Analogues PLoS One June 17, 2016
- First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine Journal of Analytical Toxicology February 19, 2015
- New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Experimental Neurology May 1, 2021
and 11 more in the library